1. Home
  2. SWIN vs RADX Comparison

SWIN vs RADX Comparison

Compare SWIN & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWIN
  • RADX
  • Stock Information
  • Founded
  • SWIN 2017
  • RADX 2021
  • Country
  • SWIN Hong Kong
  • RADX Australia
  • Employees
  • SWIN N/A
  • RADX N/A
  • Industry
  • SWIN
  • RADX
  • Sector
  • SWIN
  • RADX
  • Exchange
  • SWIN Nasdaq
  • RADX NYSE
  • Market Cap
  • SWIN 32.1M
  • RADX 32.5M
  • IPO Year
  • SWIN 2023
  • RADX N/A
  • Fundamental
  • Price
  • SWIN $4.24
  • RADX $4.05
  • Analyst Decision
  • SWIN
  • RADX Strong Buy
  • Analyst Count
  • SWIN 0
  • RADX 2
  • Target Price
  • SWIN N/A
  • RADX $13.50
  • AVG Volume (30 Days)
  • SWIN 238.6K
  • RADX 22.6K
  • Earning Date
  • SWIN 08-21-2025
  • RADX 02-26-2025
  • Dividend Yield
  • SWIN N/A
  • RADX N/A
  • EPS Growth
  • SWIN N/A
  • RADX N/A
  • EPS
  • SWIN N/A
  • RADX N/A
  • Revenue
  • SWIN $3,316,000.00
  • RADX $204,609.00
  • Revenue This Year
  • SWIN $29.79
  • RADX N/A
  • Revenue Next Year
  • SWIN $54.60
  • RADX N/A
  • P/E Ratio
  • SWIN N/A
  • RADX N/A
  • Revenue Growth
  • SWIN N/A
  • RADX N/A
  • 52 Week Low
  • SWIN $1.16
  • RADX $3.50
  • 52 Week High
  • SWIN $4.40
  • RADX $50.82
  • Technical
  • Relative Strength Index (RSI)
  • SWIN 89.09
  • RADX N/A
  • Support Level
  • SWIN $2.88
  • RADX N/A
  • Resistance Level
  • SWIN $3.48
  • RADX N/A
  • Average True Range (ATR)
  • SWIN 0.39
  • RADX 0.00
  • MACD
  • SWIN 0.16
  • RADX 0.00
  • Stochastic Oscillator
  • SWIN 93.93
  • RADX 0.00

About SWIN Solowin Holdings

Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.

About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD

Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.

Share on Social Networks: